Endothelial Protection and Improved Micro- and Macrocirculation with Hemoadsorption in Critically Ill Patients

Area of Science:

• Critical Care Medicine
• Immunology
• Vascular Biology

Background:

• Dysregulated immune responses cause excessive cytokine release, leading to vasoplegia, shock, and multiorgan failure.
• The endothelium and glycocalyx maintain vascular homeostasis but are damaged during hyperinflammation.
• Toxic proteins and cytokines contribute to endothelial and glycocalyx injury in critical illness.

Purpose of the Study:

• To review current knowledge on hyperinflammation and endothelial damage in critically ill patients.
• To explore the role of extracorporeal hemoadsorption in managing these conditions.
• To propose the hypothesis of "endothelial protection with hemoadsorption".

Main Methods:

• Literature review of in vitro, animal, and human studies.
• Analysis of data on cytokine reduction and toxic protein removal by hemoadsorption.
• Synthesis of findings to support a novel therapeutic hypothesis.

Main Results:

• Extracorporeal hemoadsorption effectively reduces circulating cytokine levels.
• Hemoadsorption may remove toxic proteins implicated in endothelial and glycocalyx damage.
• Evidence suggests potential benefits in mitigating hyperinflammatory states.

Conclusions:

• Hyperinflammation severely compromises endothelial and glycocalyx integrity.
• Extracorporeal hemoadsorption presents a promising modality for reducing inflammatory mediators.
• The hypothesis of "endothelial protection with hemoadsorption" warrants further investigation in critically ill patients.